Haywood Securities defends legitimacy of Aphria assets in analyst report

Haywood Securities defends legitimacy of Aphria assets in analyst report

An investment firm that provided a fairness opinion and valuation on a trio of controversial Latin American cannabis assets purchased by Aphria Inc. has issued a research report that appears to defend the legitimacy of those assets. In July 2018, Haywood Securities Inc. provided the opinion to Scythian Biosciences Inc., a Florida-based company that sold the package of assets based in Columbia,…

Read More